Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

3 Biotechs with Massive Growth Potential

These three biotech stocks have massive growth opportunities on the horizon, and could add a huge boost to any portfolio. They play in some of the most in demand markets on the planet, and have track records of finding ways to introduce products into those markets to capture big profits.…

StockNews.com

Three Scottish cities to apply for drug testing facilities, says minister

APPLICATIONS will be made for drug testing facilities in three Scottish cities, drugs policy minister Elena Whitham has said...

The National (Scotland)

Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke

Revance is reversing course to stay competitive with AbbVie's aesthetics drug, Botox — and RVNC stock crashed Tuesday in response.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Palatin Technologies (PTN) Stock a Biotech Buy Before Earnings?

Palatin Technologies’ (PTN) stock has plummeted more than 75% over the past year. Since its inception, the biotech company has incurred massive net losses and negative cash flows from operations. Further, it anticipates incurring additional losses in the future. So, let’s determine if PTN is a buy or sell before…

StockNews.com

Expand pharmacy capabilities to ease pressure on GPs, think tanks say

The report outlined a number of recommendations for policymakers, as well as ‘significant’ barriers facing the sector.

The Independent UK

3 Healthcare Stocks to Buy Today

The POWR Ratings system points the way to 3 of the most attractive healthcare stocks on the market today. Read on below for why you should consider adding these 3 stocks to your portfolio: Johnson & Johnson (JNJ), Amgen (AMGN) and AbbVie (ABBV).

StockNews.com

Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival

Incyte stock tumbled to a nearly five-year low Monday after GSK gained FDA approval for a rival myelofibrosis treatment.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

These 7 Stocks Are Outperforming Nvidia In 2023

Nvidia stock has tripled, but it's not No. 1 in 2023. Carvana has surged 996%, leading seven huge winners this year.

Investors Business Daily

Date set for Glasgow drug consumption room crunch talks

A KEY meeting to determine how the UK’s first safe drug consumption room could be trialled in Glasgow will go ahead before the end of this month,…

The National (Scotland)

How IBD Stock Of The Day Argenx, A Top-Notch Biotech, Is Dominating — With One Drug

Argenx is Friday's IBD Stock Of The Day. The biotech stock is climbing the right side of a cup base on enthusiasm for its drug, Vyvgart.

Investors Business Daily

Businessline Millets Conclave: Krishna Ella calls for GST waiver for millets

The Hindu

Which of these 3 Pharma Stocks Should You Buy, Hold or Sell?

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. So, let's analyze whether Johnson & Johnson (JNJ), Calliditas Therapeutics AB (CALT), and Aurora Cannabis (ACB) are a Buy, Hold, or Sell.

StockNews.com

Big Pharma's Johnson & Johnson under investigation in South Africa over 'excessive' drug prices

U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug

The Independent UK

Free prescription discount cards from GoodRx — What’s the catch?

GoodRx’s prescription savings program offers significant discounts on prescription drugs, but not without some catches

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Communities across Appalachia band together for first-ever 13-state Narcan distribution event

An effort to destigmatize the use of overdose reversal drugs that started as a pilot in two West Virginia counties has expanded to all thirteen states in Appalachia this year

The Hindu

Syngene plans to invest ₹788 cr. to expand operations in Hyderabad’s Genome Valley

Syngene to invest up to ₹788 cr in Genome Valley, Hyderabad. Expansion to create 1,000 jobs in science over 5 yrs. Inaugurated PROTAC lab & Central Compound Management facility. Ease of doing business & living in Telangana praised by Syngene's non-executive chairperson Kiran Mazumdar Shaw.

The Hindu

PM Modi to inaugurate infra projects worth ₹57,050 crore in Madhya Pradesh and Chhattisgarh

PM Modi will also lay the foundation stone for 50-bed critical care blocks in nine districts of Chhattisgarh. Read more on The Hindu

StockNews.com

3 A-Rated Pharma Stocks to Buy Today

The pharmaceutical industry is expected to grow in the upcoming years, propelled by continual advancements in medicine, aiming to meet the escalating demands for chronic disease treatment and address the needs of an aging population. Therefore, quality pharma stocks Neurocrine Biosciences (NBIX), AbbVie Inc. (ABBV), and Novo Nordisk A/S (NVO),…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Moderna Surges After Flu Shot Beats Out Widely Used Sanofi, GSK Vaccines

Moderna said Wednesday its flu shot outperformed broadly used vaccines from Sanofi and GSK. The results bolstered Moderna stock.

StockNews.com

3 Pharma Stocks Surpassing Johnson & Johnson (JNJ)

The pharmaceutical sector is anticipated to thrive as demand grows and technology advances. While Johnson & Johnson (JNJ) receives much attention from investors, I believe Horizon Therapeutics Public Limited (HZNP), Dr. Reddy’s Laboratories (RDY), and Novartis (NVS) are better investments right now. Read on.

Investors Business Daily

Can Neurocrine Erase Its Recent Setbacks With This Jump To An Eight-Month High?

Neurocrine said Tuesday its experimental drug could help lower steroid use for patients with a rare, adrenal disease. NBIX stock surged.

StockNews.com

Prescribe to Profits With These 3 Pharma Stocks

The pharma industry looks well-positioned for solid growth in the long term amid the rising incidence of chronic illnesses and technological advancements. So, quality pharma stocks, Eli Lilly and Company (LLY), Merck & Co. (MRK), and Teva Pharmaceutical (TEVA) could be profitable investments. Read on.

Investors Business Daily

Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters

Novavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid boosters from rivals Pfizer and Moderna.

Investors Business Daily

Crinetics Pharmaceuticals Just Scored A Much-Needed Win And Soared 63%

Crinetics said Monday its pill succeeded in a study of people with a growth hormone disorder. The biotech stock skyrocketed.

The Hindu

Regulator issues alert over sale of falsified versions of 2 drugs

Drugs regulator Drugs Controller General of India has directed States and Union Territories to keep vigil on sale and distribution of falsified versions of two drugs, liver medication Defitelio and Takeda’s cancer drug Adcetris after alerts from World Health Organization

1 … 38 39 40 41

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.